CitraFlow™ 30% SF products are anticoagulant and antimicrobial 30% sodium citrate prefilled syringes. They are a proven alternative to heparin for Vascular Access Devices locking as they avoid the risks associated with systemic heparinization and are safe for use in patients with suspected or confirmed Heparin Induced Thrombocytopenia.
CitraFlow™ 30% SF Prefilled Syringes by MedXL provide a sterile, single-use citrate-based locking solution designed to maintain patency and prevent occlusions in vascular access devices, such as central venous catheters. Each syringe is prefilled with a 30% trisodium citrate solution, offering safe, heparin-free anticoagulant protection that helps reduce the risk of infection and clot formation.
Manufactured in Canada under stringent quality and sterility standards, CitraFlow™ 30% SF syringes arrive ready-to-use, eliminating the need for on-site preparation or dilution. Their precision fill, smooth plunger movement, and leak-resistant barrel ensure consistent, reliable performance with every use.
The 30% formulation is ideal for routine locking of catheters and vascular access devices in hospitals, dialysis units, infusion centers, and long-term care environments. CitraFlow™ SF is latex-free, preservative-free, and compatible with a wide range of catheter materials, offering healthcare professionals a safe, efficient, and standardized approach to catheter maintenance.
